EdgeRock Capital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
EdgeRock Capital's LLY Position: Q2 2026 in Review
EdgeRock Capital increased its Eli Lilly (LLY) stake by 20% in Q2 2026, buying an estimated $203K and bringing the position to 1,189 shares worth $1.43M. The position accounts for 0.32% of the portfolio, ranked #39.
EdgeRock Capital first reported a position in LLY in Q3 2022 and has held it in 7 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- EdgeRock Capital held 1,189 shares of Eli Lilly worth $1.43M as of Q2 2026.
- EdgeRock Capital bought 199 Eli Lilly shares in Q2 2026, an estimated $203K.
- Eli Lilly made up 0.32% of EdgeRock Capital's portfolio in Q2 2026, its #39 holding.
- EdgeRock Capital first reported a position in Eli Lilly in Q3 2022 and has held it in 7 quarters since.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on EdgeRock Capital's 13F filing for Q2 2026, filed 24 Jul 2026.